+4 9 (0) 60 7 4 487 6 0
standing the test of time

Disclaimer

Product Inserts on this website are made available for ilustration purposes only. When using one of our test kits, one must use the insert provided with the kit itself.

Candida albicans

Candida albicans is a disploid asexual fungus (a form of yeast) and a causal agent of opportunistic oral and vaginal infections in humans. It is among the gut flora, the many organisms that live in the human mouth and gastrointestinal tract. Candida infections must therefore be considered endogenous.
Under normal circumstances, Candida albicans lives in 80% of the human population with no harmful effects, although overgrowth results in candidiasis. Candidiasis usually develops in persons whose immunity is compromised (such as HIV-positive patients), most frequently in the presence of disturbed cellular immunity. Diabetes, pregnancy, progesterone therapy and intensive antibiotic treatment that eliminate the normal bacterial flora are among the predisposing factors. The mucosa is affected most often, less frequently the outer skin and inner organs (deep candidiasis). In oral cavity infections, a white, stubbornly adherent coating is seen on the cheek mucosa and tongue. Skin is mainly infected on the moist, warm parts of the body. Pathomorphologically similar to oral soor is vulvovaginitis.
Candida can spread to cause secondary infections of the lungs, kidneys and other organs. Chronic mucocutaneous candidiasis is observed as a sequel to damage of the cellular immune system.
Systemic fungal infections have emerged as important causes of morbidity and mortality in immunocompromised patients. In addition, hospital-related infections in patients not previously considered at risk (e.g. patients on an intensive care unit) have become a cause of major health concern.

The new result interpretation enables to differentiate between acute infection and remaining antibodies of previous infections

New interpretation

Previous Interpretation

Calculated Cut-off

25 NTU

Cut-off

10 NTU

Grey zone

25 - 30 NTU

Grey zone

9 ? 11 NTU

Negative

<25 NTU

Negative

 < 9 NTU

Positive

 >30 NTU

Positive

 > 11 NTU

The borderline value of NovaLisa Candida albicans IgG was established in a way that most of tested serum samples from unselected blood donors showed negative or borderline results. Therefore positive IgG-results indicate an acute infection and not the remaining IgG antibodies from a previous infection. If already moderately elevated antibody titers should be detected and interpreted as positive results, a borderline region of 10-25 NTU can be also applied. In this connection, however, is has to be unconditionally observed that titers which are due to seroprevalence are no longer completely blanked out. Therefore a serological positive result has to be looked upon then very critically, especially if the clinical picture and/or results of other detection methods are not available.

Order information:

ELISA                     

Number of determinations

Product
number

Candida albicans IgA

96

CANA0060

Candida albicans IgG
2. Generation

96

CANG0060

Candida albicans IgM

96

CANM0060

Your Partner

Customer Service

info(at)novatec-id.com

Download

Flyer

Candida

Product Insert

Candida IgA